UNLIMITED TURBO LONG - RESMED | Delayed Deutsche Boerse AG 05:20:55 2024-05-16 EDT | ||
| 8.98 EUR | -1.10% |
|
| Current month | +4.61% | ||
| 1 month | +49.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-16 | 8.98 | -1.10% |
| 24-05-15 | 9.08 | +4.01% |
| 24-05-14 | 8.73 | -1.80% |
| 24-05-13 | 8.89 | +3.13% |
| 24-05-10 | 8.62 | -2.49% |
Delayed Quote Deutsche Boerse AG
Last update May 16, 2024 at 05:20 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | 
BNP Paribas
|
| WKN | PF1802 |
| ISIN | DE000PF18022 |
| Date issued | 2020-10-13 |
| Strike | 123.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.03 € |
|---|---|
| Lowest since issue | 1.7 € |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
220.6
USD
Average target price
216.6
USD
Spread / Average Target
-1.80%
- Stock Market
- Certificates
- Certificat
